ITC To Investigate PacBio's DNA Sequencer Patent Claim

Law360, New York (December 5, 2016, 6:40 PM EST) -- The U.S. International Trade Commission announced Monday it has opened an investigation into whether Oxford Nanopore Technologies Ltd.'s imported DNA sequencers violate the U.S. company Pacific Biosciences of California Inc.'s patent.

In a Oct. 31 complaint, the Menlo Park, California-based Pacific Biosciences alleged the U.K.-based Oxford's MinION and PromethION model DNA sequencers violate a patent it holds. The complaint claims Oxford's sequencer analyzes strands of DNA linked together in a way identical to the method described in Pacific Biosciences' patent.

Pacific Biosciences argued that barring the devices from import would not be detrimental to the public interest, claiming Oxford's devices are...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!